BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Gregory Fraser does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 XAIRBeyond Air Inc | Buy | $8.00 | Apr 2024 | −84.3% | Miss |
 BTMDbiote Corp | Buy | $9.00 | Jan 2024 | +41.4% | Miss |
| XAIRBeyond Air Inc | Buy | $10.00 | Nov 2023 | −88.6% | Miss |
 AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Buy | $7.00 | Nov 2023 | +86.8% | Hit |
| AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Buy | $6.00 | Sep 2023 | +109.5% | Hit |
| AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Buy | $6.00 | Aug 2023 | +42.5% | Hit |
| XAIRBeyond Air Inc | Buy | $14.00 | Jul 2023 | −96.3% | Miss |
| AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Buy | $4.00 | Mar 2023 | +328.4% | Hit |
| BTMDbiote Corp | Buy | $10.00 | Sep 2022 | +24.1% | Miss |
| XAIRBeyond Air Inc | Buy | $20.00 | Jun 2022 | −35.7% | Miss |
| XAIRBeyond Air Inc | Buy | $16.00 | Nov 2021 | −61.7% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.